GBA3 — Glucosidase Beta 3
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">GBA3 — Glucosidase Beta 3</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>GBA3</td>
</tr>
<tr>
<td class="label">Official Full Name</td>
<td>Glucosidase beta 3</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>4p15.2</td>
</tr>
<tr>
<td class="label">Gene ID</td>
<td>57733</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y5K2</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Glycoside hydrolase, family 1</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Enzyme replacement</td>
<td>GBA3 activity</td>
</tr>
<tr>
<td class="label">Small molecule activators</td>
<td>Increase activity</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Restore expression</td>
</tr>
<tr>
<td class="label">Substrate reduction</td>
<td>Reduce substrate burden</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/hypertension" style="color:#ef9a9a">Hypertension</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">9 edges</a></td>
</tr>
</table>
GBA3 is a human gene. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
The GBA3 gene encodes a member of the glycoside hydrolase family, specifically a lysosomal glucocerebrosidase enzyme. Also known as beta-glucosidase or glucosidase beta 3, this enzyme catalyzes the hydrolysis of glycolipids and is genetically distinct from the well-known [GBA](/genes/gba) gene (glucosylceramidase). GBA3 has been implicated in Parkinson's disease risk and participates in cellular lipid metabolism.
Gene Overview
Nomenclature
- Official Name: Glucosidase beta 3
- Alternate Names: β-glucosidase, glucosylceramidase 2, CBGL1
- HGNC ID: 24523
Protein Structure
GBA3 encodes a 556-amino acid protein with:
Signal Peptide: N-terminal targeting sequence for lysosomal localization
Propeptide: Cleaved during activation
catalytic Domain: Contains the active site for glucosidase activity
Carbohydrate-Binding Domain: For substrate recognitionThe enzyme is a homodimer in its active form, requiring optimal pH 4.5-5.5 for activity.
Enzymatic Function
Catalytic Activity
GBA3 hydrolyzes:
- Glucosylceramide → Glucose + Ceramide
- Glucosylsphingosine (lyso-GL1) → Glucose + Sphingosine
- Other glycolipids: Various β-glucosidic bonds
Substrate Specificity
Unlike GBA (acid β-glucosidase), GBA3 shows:
- Broader substrate specificity
- Activity toward glucosylceramide and glucosylsphingosine
- Lower catalytic efficiency toward glucosylceramide
- Potential activity toward isoflavone glucosides (genistein, daidzein)
Expression Pattern
GBA3 is expressed in:
- Liver: Hepatocytes (highest expression)
- Kidney: Renal tubules
- Small Intestine: Enterocytes
- Brain: Lower expression, various regions
- Immune Cells: Monocytes, macrophages
- Placenta: Trophoblastic cells
Lysosomal localization is mediated by the mannose-6-phosphate recognition system.
Biological Roles
GBA3 participates in glycosphingolipid catabolism:
- Sphingolipid Turnover: Breakdown of glucosylceramide for recycling
- Ceramide Generation: Provides ceramide for signaling molecules
- Membrane Composition: Maintains proper lipid bilayer composition
- Cell Homeostasis: Prevents accumulation of glycosphingolipids
Unique to GBA3, the enzyme can hydrolyze:
- Genistein glucoside (daidzein)
- Daidzin
- Glycitin
This suggests a role in dietary isoflavone metabolism, particularly relevant for Asian populations with high soy intake.
Potential Neuroprotective Functions
In the brain, GBA3 may:
- Process glucosylceramide in neurons
- Generate ceramide for pro-survival signaling
- Interact with α-synuclein clearance pathways
Clinical Significance
Parkinson's Disease
The GBA gene is a well-established PD risk factor. GBA3 has also been studied:
Genetic Association: Some GBA3 variants may modify PD risk
Expression Changes: Altered GBA3 expression in PD brains
Functional Impact: Reduced GBA3 activity may contribute to glycolipid accumulationResearch is ongoing to determine if GBA3 variants:
- Increase susceptibility to α-synuclein pathology
- Modify disease severity
- Influence treatment response
Gaucher Disease
While GBA (not GBA3) is the primary gene causing Gaucher disease, GBA3 variants:
- May modify disease severity in GBA carriers
- Could provide compensation for GBA deficiency
- Are being studied for therapeutic potential
Other Associations
- Type 2 Diabetes: Some studies link GBA3 variants to glucose metabolism
- Liver Disease: Potential role in glycolipid metabolism in hepatocytes
- Isoflavone Response: May influence response to soy-based therapies
Interaction Network
GBA3 interacts with:
- GBA (glucosylceramidase) - Paralogs
- GBA2 (non-lysosomal glucosylceramidase)
- ASM (acid sphingomyelinase)
- GALC (galactocerebrosidase)
Lysosomal Proteins
- LAMP1, LAMP2 (lysosomal membrane proteins)
- CTSB, CTSD (cathepsins)
- GLA (α-galactosidase A)
Signaling Molecules
- Ceramide and its metabolites
- Sphingosine-1-phosphate
- Glucosylceramide
Genetic Variants
Known Polymorphisms
Several SNPs in GBA3 have been studied:
- rs2010963: In 5'UTR, affects expression
- rs4556890: In coding region
- rs1054892: Missense variant
Functional Variants
- rs2234246: Associated with enzyme activity
- rs3743548: In regulatory region
- Various rare variants with unknown function
Population Genetics
- Different allele frequencies across populations
- Positive selection in some East Asian populations (possibly due to isoflavone metabolism)
Model Systems
- Knockout mice: Gba3 knockout mice are viable
- Zebrafish models: For developmental studies
- In vitro expression: HEK293, COS cells
- Yeast models: For enzymatic studies
- Substrates: Fluorescent glucosylceramide analogs
- Inhibitors: Specific inhibitors being developed
- Antibodies: For protein detection
- Recombinant proteins: For structural studies
Therapeutic Potential
Implications for Parkinson's Disease
Understanding GBA3 may help:
- Explain variability in GBA-associated PD
- Develop targeted therapies
- Identify biomarkers for risk stratification
Summary
GBA3 encodes a lysosomal β-glucosidase with roles in glycolipid metabolism and potential implications for Parkinson's disease. While less studied than its paralog GBA, this enzyme contributes to:
- Glucosylceramide and glucosylsphingosine catabolism
- Isoflavone metabolism (unique function)
- Cellular lipid homeostasis
Further research is needed to clarify GBA3's role in neurodegeneration and explore its therapeutic potential.
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [NCBI Gene: GBA3](https://www.ncbi.nlm.nih.gov/gene/?term=GBA3)
- [GeneCards: GBA3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GBA3)
- [OMIM: GBA3](https://omim.org/search?search=GBA3)
- [Ensembl: GBA3](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=GBA3)
- [Allen Brain Atlas: GBA3](https://human.brain-map.org/microarray/search/show?search_term=GBA3)
References
Unknown, GBA3 gene information (n.d.)
Unknown, β-glucosidase structure and function (n.d.)
[Unknown, Glycosphingolipid metabolism (n.d.)](https://pubmed.ncbi.nlm.nih.gov/12586814/)
[Unknown, GBA gene in Parkinson's disease (n.d.)](https://pubmed.ncbi.nlm.nih.gov/24614576/)
[Unknown, Isoflavone metabolism by β-glucosidases (n.d.)](https://pubmed.ncbi.nlm.nih.gov/11880583/)
[Unknown, Lysosomal glucocerebrosidases (n.d.)](https://pubmed.ncbi.nlm.nih.gov/25671299/)
[Unknown, Glycolipid accumulation in neurodegeneration (n.d.)](https://pubmed.ncbi.nlm.nih.gov/28087714/)Pathway Diagram
The following diagram shows the key molecular relationships involving GBA3 — Glucosidase Beta 3 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)